DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced it would report its financial results for the fourth quarter and full year of 2006 on Wednesday, March 7, 2007 after the close of the financial markets. The announcement will be followed by a conference call scheduled for the next morning, Thursday, March 8, 2007, with the investment community at 11:00AM EST.
